Janus Henderson Group
IMNM icon

Janus Henderson Group’s Immunome IMNM Stock Holding History

Janus Henderson Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7M Sell
808,019
-24,059
-3% -$535K 0.01% 628
2025
Q4 		$17.9M Buy
832,078
+68,903
+9% +$1.21M 0.01% 630
2025
Q3 		$8.94M Sell
763,175
-277,239
-27% -$2.76M ﹤0.01% 767
2025
Q2 		$9.68M Sell
1,040,414
-1,048,081
-50% -$8.59M ﹤0.01% 733
2025
Q1 		$14.6M Sell
2,088,495
-1,367,444
-40% -$13.1M 0.01% 633
2024
Q4 		$36.7M Sell
3,455,939
-32,182
-0.9% -$389K 0.02% 449
2024
Q3 		$51M Buy
3,488,121
+324,614
+10% +$4.61M 0.03% 383
2024
Q2 		$38.3M Buy
3,163,507
+1,625,093
+106% +$25.4M 0.02% 438
2024
Q1 		$38M Buy
1,538,414
+146,943
+11% +$2.98M 0.02% 444
2023
Q4 		$14.9M Buy
+1,391,471
New +$11.6M 0.01% 597

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Janus Henderson Group's IMNM Position: Q1 2026 in Review

Janus Henderson Group reduced its Immunome (IMNM) stake by 2.9% in Q1 2026, selling an estimated $535K and leaving 808,019 shares worth $17.7M. The position accounts for 0.01% of the portfolio, ranked #628.

Janus Henderson Group first reported a position in IMNM in Q4 2023 and has held it in 10 quarters since. The position peaked at $51M in Q3 2024. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Janus Henderson Group held 808,019 shares of Immunome worth $17.7M as of Q1 2026.
  • Janus Henderson Group sold 24,059 Immunome shares in Q1 2026, an estimated $535K.
  • Immunome made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #628 holding.
  • Janus Henderson Group first reported a position in Immunome in Q4 2023 and has held it in 10 quarters since.
  • Janus Henderson Group's Immunome position peaked at $51M in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.